NCT05202210

Brief Summary

The present study will establish a collection of biological samples from Noonan patients to be used for research purposes only, with due respect for confidentiality.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
70mo left

Started Jan 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
Jan 2022Jan 2032

First Submitted

Initial submission to the registry

January 7, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 21, 2022

Completed
5 days until next milestone

Study Start

First participant enrolled

January 26, 2022

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 26, 2027

Expected
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 26, 2032

Last Updated

March 19, 2026

Status Verified

March 1, 2026

Enrollment Period

5 years

First QC Date

January 7, 2022

Last Update Submit

March 16, 2026

Conditions

Keywords

Biological collectionNoonan Syndrome

Outcome Measures

Primary Outcomes (1)

  • Constitution of a biological collection from patients with Noonan or related syndromes.

    extra sample of blood and urine will be collected

    inclusion

Study Arms (1)

patients with Noonan syndrome

extra sample of blood and urine will be collected and stored for research utilisation

Biological: blood and urine sampling

Interventions

extra sample of blood and urine will be collected

patients with Noonan syndrome

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with Noonan syndrome

You may qualify if:

  • Children aged at least 3 years old or adult with Noonan syndrome
  • Patients affiliated to or beneficiaries of a social security scheme
  • Patients able to receive information on the progress of the study and understand the information form to participate in the study. That implies to master the French language and not to be subject to a restriction of rights by the judicial authorities
  • Patients or legal representative who have given their consent to participate in the study (expression of no objection)

You may not qualify if:

  • Patients subject to a legal protection measure (guardianship, curators, or safeguard of justice)
  • Pregnant or breastfeeding women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Purpan University Hospital

Toulouse, 31059, France

RECRUITING

MeSH Terms

Conditions

Noonan Syndrome

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Craniofacial AbnormalitiesMusculoskeletal AbnormalitiesMusculoskeletal DiseasesHeart Defects, CongenitalCardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesConnective Tissue DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Thomas EDOUARD, MD PhD

    University Hospital, Toulouse

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Thomas EDOUARD, MD, PhD

CONTACT

Françoise Auriol, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 7, 2022

First Posted

January 21, 2022

Study Start

January 26, 2022

Primary Completion (Estimated)

January 26, 2027

Study Completion (Estimated)

January 26, 2032

Last Updated

March 19, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations